Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Anti-osteoarthritic effects of ChondroT in a rat model of collagenase-induced osteoarthritis

Authors: Jiwon Jeong, Kiljoon Bae, Sun-Gil Kim, Dongwook Kwak, Young-Joo Moon, Chan-Hun Choi, Young-Ran Kim, Chang-Su Na, Seon-Jong Kim

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Previously, we reported that ChondorT showed significant anti-arthritis and anti-inflammatory effects. ChondroT, a new herbal medication, consists of the water extracts of Osterici Radix, Lonicerae Folium, Angelicae Gigantis Radix, Clematidis Radix, and Phellodendri Cortex (6:4:4:4:3). The objective of this study was to investigate the effects of ChondroT in collagenase-induced osteoarthritis rat model.

Methods

Osteoarthritis was induced by the injection of collagenase into the right knee joint cavity of rats. The samples were divided into seven groups [intact (n = 6), control (n = 6), indomethacin (n = 6), Joins tab (n = 6), ChondroT50 (n = 6), ChondroT100 (n = 6), and ChondroT200 (n = 6)]. The control group was administered normal saline, indomethacin group was administered indomethacin (2 mg/kg), and Joins tab group was administered Joins Tab (20 mg/kg). The ChondroT50, ChondroT100, and ChondroT200 groups were administered 50, 100, and 200 mg/kg of ChondroT, respectively. All oral administrations were initiated 7 days after the induction of arthritis and were continued for a total of 12 days. At the end of the experiment, serum aminotransferase, albumin, blood urea nitrogen, creatinine, leukocyte, and inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6] were analyzed. Hematoxylin and eosin (H&E) and safranin O-fast green staining of the articular structures of the knee joint were performed.

Results

TNF-α and IL-1β decreased in the ChondroT100 and ChondroT200 groups compared with those in the control group. IL-6 and aspartate aminotransferase decreased in the ChondroT50, ChondroT100, and ChondroT200 groups compared with that in the control group. Albumin, WBC and lymphocytes decreased in the ChondroT100 and ChondroT200 groups compared with those in the control group. In H&E stain, synoviocytes, cartilage lacunae, and chondrocytes were well preserved in the ChondroT100 and ChondroT200 groups, and safranin O-fast staining showed a clear reaction of proteoglycans in the ChondroT100 and ChondroT200 groups.

Conclusions

Based on these results, it can be proposed that ChondroT has anti-osteoarthritic effects on collagenase-induced rat model.
Literature
1.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323–30.CrossRefPubMed
2.
Kim JH, Ryu KH, Jung KW, Han CK, Kwak WJ, Cho YB. Effects of SKI306X on arachidonate metabolism and other inflammatory mediators. Biol Pharm Bull. 2005;28:1615–20.CrossRefPubMed
3.
4.
5.
Zeng L, Wang W, Rong XF, Zhong Y, Jia P, Zhou GQ. Chondroprotective effects and multi-target mechanisms of icariin in IL-1 beta-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis model. Int Immunopharmacol. 2014;18:175–81.CrossRefPubMed
6.
Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, et al. Role of interleukin-1 and tumor necrosis factor ? In matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52:128–35.CrossRefPubMed
7.
Chadjichristos C, Ghayor C, Kypriotou M, Martin G, Renard E, Ala-Kokko L, et al. Sp1 and Sp3 transcription factors mediate interleukin-1β down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem. 2003;278:39762–72.CrossRefPubMed
8.
Choi HM, Oh DH, Bang JS, Yang H-I, Yoo MC, Kim KS. Differential effect of IL-1β and TNF-α on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages. Rheumatol Int. 2010;30:1025–33.CrossRefPubMed
9.
Kim YH, Lee JH. CheongKangEuiGam. Seoul: Seongbosa; 2001. p. 315.
10.
Jeoung BR, Lee KD, Na CS, Kim YE, Kim B, Kim YR. Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: the therapeutic effect of GHJTY on rheumatoid arthritis. BMC Complement Altern Med. 2013;13:47–52.CrossRefPubMedPubMedCentral
11.
12.
Park JU, Kim SJ, Na CS, Choi C, Seo CS, Son JK, et al. Chondroprotective and anti-inflammatory effects of ChondroT, a new complex herbal medication. BMC Complement Altern Med. 2016;16:213–23.CrossRefPubMedPubMedCentral
13.
Kim W, Park S, Choi C, Kim YR, Park I, Seo C, et al. Evaluation of anti-inflammatory potential of the new Ganghwaljetongyeum on adjuvant-induced inflammatory arthritis in rats. Evid Based Complement Alternat Med. 2016;2016 https://​doi.​org/​10.​1155/​2016/​1230294.
14.
Blom AB, van Lent PL, Libregts S, Holthuysen AE, van der Kraan PM, van Rooijen N, et al. Crucial role of macrophages in matrix metalloproteinase–mediated cartilage destruction during experimental osteoarthritis : involvement of matrix metalloproteinase 3. Arthritis Rheum. 2007;56:147–57.CrossRefPubMed
15.
Botter SM, van Osch GJVM, Waarsing JH, van der Linden JC, Verhaar JAN, Pols HAP, et al. Cartilage damage pattern in relation to subchondral plate thickness in a collagenase-induced model of osteoarthritis. Osteoarthr Cartil. 2008;16:506–14.CrossRefPubMed
16.
Seo BK, Sung WS, Park YC, Baek YH. The electroacupuncture-induced analgesic effect mediated by 5-HT1, 5-HT3 receptor and muscarinic cholinergic receptors in rat model of collagenase-induced osteoarthritis. BMC Complement Altern Med. 2016;16:212–22.CrossRefPubMedPubMedCentral
17.
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Osteoarthr Cartil. 2010;18:476–99.CrossRefPubMed
18.
Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6–12 months) safety of acetaminophen in adult patients with osteoarthritis. Clin Ther. 2006;28:222–35.CrossRefPubMed
19.
Emery CA, Roos EM, Verhagen E, Finch CF, Bennell KL, Story B, et al. OARSI clinical trials recommendations: design and conduct of clinical trials for primary prevention of osteoarthritis by joint injury prevention in sport and recreation. Osteoarthr Cartil. 2015;23:815–25.CrossRefPubMed
20.
Farzaei MH, Farzaei F, Gooshe M, Abbasabadi Z, Rezaei N, Abdolghaffari AH. Potentially effective natural drugs in treatment for the most common rheumatic disorder: osteoarthritis. Rheumatol Int. 2015;35:799–814.CrossRefPubMed
21.
Iannitti T, Lodi D, Palmieri A. Intra-articular injections for the treatment of osteoarthritis. Drugs R D. 2011;11:13–27.CrossRefPubMed
22.
Park KK, Choi CH, Ha C-W, Lee MC. The effects of adherence to non-steroidal anti-inflammatory drugs and factors influencing drug adherence in patients with knee osteoarthritis. J Korean Med Sci. 2016;31:795–816.CrossRefPubMedPubMedCentral
23.
Massó González EL, Patrignani P, Tacconelli S, Rodríguez LAG. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010;62:1592–601.CrossRefPubMed
24.
McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase. JAMA. 2006;296:1633–44.CrossRefPubMed
25.
Hatori M, Kokubun S. Clinical evaluation of indomethacin-containing patches for osteoarthritis and extremity trauma. Curr Med Res Opin. 1997;13:511–5.CrossRefPubMed
26.
27.
Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, et al. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis res. Ther. 2013;15:R25.
28.
Kornasoff D, Maisenbacher J, Bowdler J, Raber A. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. Rheumatol Int. 1996;15:225–30.CrossRefPubMed
29.
Jung YB, Roh KJ, Jung JA, Jung K, Yoo H, Cho YB, et al. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study. Am J Chin Med. 2001;29:485–91.CrossRefPubMed
30.
Lee CW, Park SM, Kim YS, Jegal KH, Lee JR, Cho IJ, et al. Biomolecular evidence of anti-inflammatory effects by Clematis mandshurica Ruprecht root extract in rodent cells. J Ethnopharmacol. 2014;155:1141–55.CrossRefPubMed
31.
Suh SJ, Kim KS, Lee SD, Lee CH, Choi HS, Jin U-H, et al. Effects and mechanisms of Clematis mandshurica maxim. As a dual inhibitor of proinflammatory cytokines on adjuvant arthritis in rats. Environ Toxicol Pharmacol. 2006;22:205–12.CrossRefPubMed
32.
Varas A, Valencia J, Lavocat F, Martínez VG, Thiam NN, Hidalgo L, et al. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes. Arthritis Res Ther. 2015;17:192–201.CrossRefPubMedPubMedCentral
33.
Hulejová H, Barešová V, Klézl Z, Polanská M, Adam M, Šenolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38:151–6.CrossRefPubMed
34.
Valdes AM, Arden NK, Tamm A, Kisand K, Doherty S, Pola E, et al. A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthr Cartil. 2010;18:699–704.CrossRefPubMed
35.
Yuan PW, Liu DY, Chu XD, Hao YQ, Zhu C, Qu Q. Effects of preventive Administration of Juanbi Capsules on TNF-α IL-1 and IL-6 contents of joint fluid in the rabbit with knee osteoarthritis. J Tradit Chin Med. 2010;30:254–8.CrossRefPubMed
36.
Lee SH, Kwon KD, Lee SW, Ahn HS. Acetabular degeneration in osteonecrosis of the femoral head. J Korean Orthop Assoc. 2004;39:239–46.CrossRef
37.
Nieuwenhuizen L, Roosendaal G, Mastbergen SC, Coeleveld K, Biesma DH, Lafeber FPJG, et al. Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. J Thromb Haemost. 2014;12:237–45.CrossRefPubMed
38.
Tiraloche G, Girard C, Chouinard L, Sampalis J, Moquin L, Ionescu M, et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum. 2005;52:1118–28.CrossRefPubMed
Metadata
Title
Anti-osteoarthritic effects of ChondroT in a rat model of collagenase-induced osteoarthritis
Authors
Jiwon Jeong
Kiljoon Bae
Sun-Gil Kim
Dongwook Kwak
Young-Joo Moon
Chan-Hun Choi
Young-Ran Kim
Chang-Su Na
Seon-Jong Kim
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2149-1

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Herbal formula Xinshuitong capsule exerts its cardioprotective effects via mitochondria in the hypoxia-reoxygenated human cardiomyocytes

Research article

A survey of Korean medicine doctors’ clinical practice patterns for autism spectrum disorder: preliminary research for clinical practice guidelines

Research article

Glycolysis inhibition via mTOR suppression is a key step in cardamonin-induced autophagy in SKOV3 cells

Study protocol

Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) – a double-blind, randomized, controlled comparative effectiveness trial

Research article

Brazilian propolis ethanol extract and its component kaempferol induce myeloid-derived suppressor cells from macrophages of mice in vivo and in vitro

Research article

Comparison of the main components and bioactivity of Rhus verniciflua Stokes extracts by different detoxification processing methods